Laksh Aithani, ex-Charm Therapeutics CEO
April 16, 2025 05:20 PM EDT
People
AI

Ex­clu­sive: Charm Ther­a­peu­tic­s' founder steps down as CEO, as AI biotech eyes clin­ic in 2026

Andrew Dunn

Senior Biopharma Correspondent

The Lon­don biotech Charm Ther­a­peu­tics is look­ing for a new top ex­ec­u­tive to re­place found­ing CEO Laksh Aithani, End­points News has learned.

Aithani co-found­ed the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sanofi to pay $125M up­front for two im­munol­o­gy drugs from lit­tle-known biotech

US drugs re­ly heav­i­ly on in­gre­di­ents made over­seas, new re­port shows

Ex­clu­sive: VelaV­i­go inks an­oth­er US biotech deal as Chi­na drug de­vel­op­ment scene booms

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

Sarep­ta los­es CMO to RNA edit­ing up­start; An­oth­er wave of per­son­nel moves at Dyne

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times